临床荟萃 ›› 2025, Vol. 40 ›› Issue (9): 816-820.doi: 10.3969/j.issn.1004-583X.2025.09.007

• 论著 • 上一篇    下一篇

基于SEER数据库的结直肠癌肝转移危险因素分析:倾向评分匹配研究

韦婷婷, 潘正燕, 冯鲜燕, 龙亚秀()   

  1. 来宾市人民医院 肿瘤科,广西 来宾 546199
  • 收稿日期:2025-08-25 出版日期:2025-09-20 发布日期:2025-09-26
  • 通讯作者: 龙亚秀 E-mail:weitt@163.com

Analysis of risk factors for colorectal cancer with liver metastasis based on the SEER database: A propensity score matching study

Wei Tingting, Pan Zhengyan, Feng Xianyan, Long Yaxiu()   

  1. Department of Oncology,the People's Hospital of Laibin,Laibin 546199,China
  • Received:2025-08-25 Online:2025-09-20 Published:2025-09-26
  • Contact: Long Yaxiu E-mail:weitt@163.com

摘要:

目的 基于SEER数据库分析结直肠癌发生肝转移的独立风险因素。方法 提取SEER数据库中2010-2019年的结直肠癌患者60 136例,其中发生肝转移5 072例。采用倾向性评分(PSM)(1∶1)平衡肝转移组和非转移组的临床基线特征,最终筛选出9 716例(每组4 858例)匹配后样本。分别于匹配前和匹配后应用单因素logistics回归分析来筛选肝转移的风险因素。结果 在匹配前,基于单因素logistics回归分析,12个因素(年龄、性别、种族、T期、N期、放疗、化疗、脑转移、骨转移、肺转移、远处淋巴结转移和其他少见部位转移)是肝转移的独立危险因素。匹配后,化疗和其他少见部位转移是肝转移的保护因素( O R<1),而骨、肺转移是肝转移的独立危险因素。此外,在原发肿瘤部位中,在横结肠发生率最高为9.86%,其次是直乙状结肠癌8.91%。结论 化疗作为结直肠癌肝转移的保护因素,其重要性不容忽视,对于已经发生骨、肺转移的结直肠癌患者,应加强对肝转移的监测和干预,以制定个性化的治疗方案,改善患者预后。

关键词: 结直肠肿瘤, 肝转移, 倾向性匹配分析, 危险因素

Abstract:

Objective To analyze independent risk factors for liver metastasis in colorectal cancer based on the SEER database. Methods A total of 60, 136 colorectal cancer patients from the SEER database between 2010 and 2019 were included, among whom 5, 072 developed liver metastases. Propensity score matching(PSM)(1∶1) was used to balance the baseline clinical characteristics between the liver metastasis and non-metastasis groups, resulting in a matched cohort of 9, 716 patients with 4, 858 cases in each group. Univariate logistic regression analysis was applied both before and after matching the identified risk factors for liver metastasis. Results Before matching, univariate logistic regression analysis identified 12 factors(age, sex, race, T stage, N stage, radiotherapy, chemotherapy, brain metastasis, bone metastasis, lung metastasis, distant lymph node metastasis, and other rare site metastases) as independent risk factors for liver metastasis. After matching, chemotherapy and metastasis to other rare sites were identified as protective factors against liver metastasis in colorectal cancer(OR<1), while bone and lung metastases were independent risk factors. Additionally, among primary tumor sites, the highest incidence of liver metastasis was observed in the transverse colon(9.86%), followed by the rectosigmoid colon(8.91%). Conclusion The importance of chemotherapy as a protective factor against liver metastasis in colorectal cancer should be highlighted. For colorectal cancer patients who have already developed bone or lung metastases, enhanced monitoring and intervention for liver metastasis are essential to develop personalized treatment strategies and improve the prognosis.

Key words: colorectal neoplasms, liver metastasis, propensity score matching, risk factors

中图分类号: